Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  SHANGHAI STOCK EXCHANGE  >  Jiangsu Hengrui Medicine Co Ltd    600276   CNE0000014W7

JIANGSU HENGRUI MEDICINE CO LTD (600276)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shanghai Stock Exchange
07/10/2018 07/11/2018 07/12/2018 07/13/2018 07/16/2018 Date
72.84(c) 72.37(c) 73.7(c) 74.99(c) 74.71 Last
157 070 192 821 241 162 237 112 137 179 Volume
+0.76% -0.65% +1.84% +1.75% -0.37% Change
More quotes
Financials (CNY)
Sales 2018 17 054 M
EBIT 2018 4 478 M
Net income 2018 3 891 M
Finance 2018 8 363 M
Yield 2018 0,15%
Sales 2019 21 471 M
EBIT 2019 5 775 M
Net income 2019 4 971 M
Finance 2019 11 409 M
Yield 2019 0,18%
P/E ratio 2018 70,07
P/E ratio 2019 54,71
EV / Sales2018 15,7x
EV / Sales2019 12,3x
Capitalization 276 B
More Financials
Company
Jiangsu Hengrui Medicine Co., Ltd. engages in the research, development, manufacture, and sale of drugs.It specializes in antineoplastic agents, surgical anesthesia drugs, features infusion, contrast agents, and cardiovascular drugs.Its products include tablets, oral solution, and suspension of... 
Sector
Pharmaceuticals
Calendar
08/10Earnings Release
More about the company
Surperformance© ratings of Jiangsu Hengrui Medicine C
Trading Rating : Investor Rating :
More Ratings
Latest news on JIANGSU HENGRUI MEDICINE C
05/30JIANGSU HENGRUI MEDICINE CO LTD : BONUS ISSUE: 3 new shares for 10 existing shar..
FA
05/30JIANGSU HENGRUI MEDICINE CO LTD : Ex-dividend day for final dividend
FA
05/17JIANGSU HENGRUI MEDICINE : Researchers Submit Patent Application, "P-Toluenesulf..
AQ
05/03JIANGSU HENGRUI MEDICINE : Patent Issued for Aminopyridazinone Compounds as Prot..
AQ
04/26JIANGSU HENGRUI MEDICINE : Researchers Submit Patent Application, "Anti-Sclerost..
AQ
04/11JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
03/28JIANGSU HENGRUI MEDICINE : Procurement Project for Automatic Labeler Machine for..
AQ
03/27JIANGSU HENGRUI MEDICINE CO LTD : annual earnings release
01/19JIANGSU HENGRUI MEDICINE : and Arcutis Announce a Development and Commercializat..
AQ
01/09TG THERAPEUTICS : and Jiangsu Hengrui Medicine Announce Global License Agreement..
AQ
More news
Sector news : Pharmaceuticals - NEC
07/14INDIVIOR : wins preliminary injunction against generic rival
RE
07/13TEVA PHARMACEUTICAL INDUSTRIES : FDA Recalls Several Medicines That Contain Vals..
DJ
07/13NOVARTIS : Played Down Ties to Trump Lawyer Michael Cohen, Report Says
DJ
07/13JOHNSON & JOHNSON : J&J vows to overturn $4.7 billion talc verdict but experts s..
RE
07/13NOVARTIS : disputes U.S. senators' report on Cohen contract
RE
More sector news : Pharmaceuticals - NEC
Latest Tweets
01/08$TGTX: TG Therapeutics and Jiangsu Hengrui Medicine announce global license a.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
01/05Jiangsu Hengrui Medicine and Arcutis Announce a Development and Commercializa.. 
2017Oncolys Biopharma : Announces First Milestone from License Agreement with Jia.. 
More tweets
Qtime:39
Chart JIANGSU HENGRUI MEDICINE C
Duration : Period :
Jiangsu Hengrui Medicine C Technical Analysis Chart | 600276 | CNE0000014W7 | 4-Traders
Technical analysis trends JIANGSU HENGRUI MEDICINE C
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 24
Average target price 68,9  CNY
Spread / Average Target -8,1%
EPS Revisions
Managers
NameTitle
Yun Shu Zhou President & Director
Wei Dong Chairman-Supervisory Board
Piao Yang Sun Chairman
Song Zhou Chief Financial Officer
Xin Hua Jiang Vice Chairman
Sector and Competitors
1st jan.Capitalization (M$)
JIANGSU HENGRUI MEDICINE CO LTD41.33%41 278
JOHNSON & JOHNSON-8.56%337 763
PFIZER3.59%219 534
NOVARTIS-3.93%201 464
ROCHE HOLDING LTD.-5.60%200 973
MERCK AND COMPANY11.76%169 193